Guardant Health Stock News

Guardant Health Inc (GH) shares closed 2.9% lower than its previous 52 week low, giving the company a market cap of $6B. The stock is currently down 35.7% year-to-date, down 57.1% over the past 12 months, and up 99.7% over the past five years. This week, the Dow Jones Industrial Average fell 2.5%, and the S&P 500 fell 4.1%. Trading Activity Trading volume this week was 57.2% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.4. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 70.9% The company's stock price performance over the past 12 months lags the peer average by 285.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Guardant Health (GH) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revi

Viking Global Investors leader Andreas Halvorsen (Trades, Portfolio) disclosed earlier this week he boosted his stake in Guardant Health Inc. ( GH , Financial) by 4.65%.

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will present data highlighting the clinical utility of its liquid bi

The healthcare company can't provide a clear picture of where it is with respect to the COVID-19 pandemic.

Guardant Health (GH) reaches an agreement to settle all pending litigation concerning its digital sequencing technology patents with Foundation Medicine.Foundation Medicine will pay GH

Sigma Planning Corp lowered its position in shares of Guardant Health, Inc. (NASDAQ:GH) by 23.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,390 shares of the companys stock after selling 1,622 shares during the period. Sigma Planning Corps holdings in []

Guardant Health, Inc. (NASDAQ:GH) Director Stanley J. Meresman sold 4,934 shares of the stock in a transaction that occurred on Friday, December 10th. The shares were sold at an average price of $95.59, for a total transaction of $471,641.06. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is []

NUR-SULTAN, Kazakhstan , Dec. 16, 2021 /PRNewswire/ -- In November 2021 partnership agreements were signed between Astana Hub, TransTelecom JSC, and Plug and Play Kazakhstan . The parties intend to work together to develop the startup ecosystem, attract investment, create and conduct acceleration programs and assist companies in reaching their innovation goals. "Today, society recognizes the importance of developing a startup ecosystem as a factor of economic development. We are convinced of the need for long-term and effective cooperation in the interests of our partners and the community, and we believe that it will contribute to strengthening the development of the startup ecosystem in Kazakhstan ," said Sanjar Taromi , country manager of Plug and Play Kazakhstan. Plug and Play Kazakhstan, Astana Hub, and TransTelecom JSC have launched a corporate accelerator for 20 local and international startups. They will be able to advance skillsets under the mentorship of global experts, determine product-market fit, attract investments, scale up to other markets and launch pilots with leading corporations.

Harel Insurance Investments & Financial Services Ltd. reduced its stake in shares of Guardant Health, Inc. (NASDAQ:GH) by 33.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,871 shares of the companys stock after selling 2,948 shares during the quarter. Harel Insurance Investments []

Related Stocks: AMGN , GH , IDXX , ALNY , NVAX , SRPT , ICLR , BHVN , CTLT , CRBU , AZN , RLYB , ABT , ASND , NBIX , DXCM , ARNA , ARGX , DCPH , BBIO , RMD , BPMC , ALLK , IOVA ,

Sicart Associates LLC increased its stake in Guardant Health, Inc. (NASDAQ:GH) by 3.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 41,842 shares of the companys stock after acquiring an additional 1,322 shares during the period. Guardant Health []

Guardant Health, Inc. (NASDAQ:GH)s share price hit a new 52-week low on Friday . The company traded as low as $89.04 and last traded at $89.13, with a volume of 6519 shares changing hands. The stock had previously closed at $95.98. Several research firms have issued reports on GH. SVB Leerink reduced their price objective [] The post Guardant Health (NASDAQ:GH) Hits New 12-Month Low at $89.04 appeared first on ETF Daily News .